Synthetic Lipid Market Size (2023– 2030)

The Global Synthetic Lipid Market was valued at USD 2.22 Million and is projected to reach a market size of USD 3.29 Million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 5.8%.

INDUSTRY OVERVIEW

Lipids are small, waxy, fatty, and oily microbiomolecules that may dissolve in amines, ethers, ketones, and methanol, among other organic solvents. They come from butter, oil, cheese, almonds, avocados, maize, olives, and other foods. They may be divided primarily into three types: sterols, which aid in the synthesis of hormones; phospholipids, which form a barrier surrounding cells to aid in maintenance; and triglycerides, which lessen inflammation. Lipids contribute to the structural integrity of cell membranes, serve as a source of energy, and are crucial signalling molecules. Lipids are used to make agrichemicals, hydraulic fluids, inks, solvents, cosmetics, and medicinal items in addition to their biological uses.

Due to their critical significance in the development of RNA therapies and vaccines for illnesses including cancer and COVID-19, synthetic lipids are receiving increased impetus. The U.S. Food and Therapeutic Administration (FDA) has now authorised 18 liposomal medications, and there are hundreds of lipid-based drug candidates in clinical trials for a variety of diseases. Synthetic lipids have shown potential in drug development and delivery because of their capacity to improve active pharmaceutical ingredient (API) stability by shielding the API from immune response, proteases, and other factors, increase the solubility and bioavailability of drugs with low water solubility, complacently target inflamed or tumour tissues due to their leaky vasculature, improve the toxicity profile of the entrapped API, and deliver challenging APIs like RNA. Nucleic acid delivery for APIs like short RNAs for gene silencing or activation (for example, siRNA, miRNA, siRNA) and long RNA (mRNA) for applications in cancer therapy, enzyme replacement therapy, vaccines, and more represents the most recent developments in lipid-based drug delivery research and drug development. An mRNA vaccine that contained a viral antigen's mRNA inside a lipid nanoparticle was the first COVID-19 vaccine to reach clinical testing. The development of many additional lipid-based gene therapy medications will be approved in the coming years as a result of the COVID-19 RNA vaccine's success.

The incidence of obesity and other health-related problems has significantly increased as a result of rapid urbanisation, sedentary lifestyles, and increased fast food consumption. As a result, people are becoming more health concerned, and demand for nutritious lipids is rising everywhere. To preserve the flavour and aroma of their products, several food production businesses also use lipids as an alternative to synthetic flavouring transporters. This is also attributable to their outstanding functional qualities, which include emulsification, hydrogenation, and density.

Additionally, as a result of the coronavirus disease epidemic (COVID-19), the demand for lipid-based supplements is considerably increasing due to their health advantages. In addition, major businesses are developing nutritious components to increase their market share in the pharmaceutical and food and beverage (F&B) sectors. To boost total sales, they also heavily rely on advertising campaigns that feature celebrity endorsements. Additionally, the global demand for synthetic lipid supplements is being favourably impacted by the growing vegan and vegetarian population as well as the expanding necessity to complement daily diets with enough nutrients.

COVD-19 IMPACT ON THE SYNTHETIC LIPID MARKET

With the advent of COVID-19, there is now more competition among drugs for synthetic lipids. To combat the COVID-19 infection, academics and healthcare professionals are looking for new approaches. To conserve enormous amounts of lipids for use in COVID-19 vaccine testing in 2020, Moderna Inc. and CordenPharma have announced their cooperation. Additionally, it was announced that if the vaccine proved to be successful, one million doses would be distributed each month until 2021, when 10 million doses would be distributed. Businesses across all sectors have been severely impacted by the lockdown and government-imposed restrictions brought on by the coronavirus. Significantly impacted are both the private healthcare industry and health enterprises that depend on having direct physical touch with their clientele. Numerous small clinics, hospitals, and nursing homes were compelled to close. Procedures have been held up by social isolation and regional curfews. Additionally, the halt in medical tourism caused by visa cancellations might have a detrimental effect on the expansion of the healthcare services sector.

MARKET DRIVERS: 

Synthetic lipids provide the required consistency in purity which is a major growth proponent

The final liposome formulations' impurity profile and features, such as the particle characteristics, bilayer structure, stability, and drug-release profile, are directly influenced by the lipid type, source, quality, and purity. It is crucial to synthesise lipids exclusively from premium raw materials with ideal material properties and consistent quality for reproducible outcomes. Chemically produced lipids or synthetic lipids have an advantage over naturally occurring lipids since they are made of a single, high-quality lipid, whereas tissue-derived lipids are typically a blend of lipids from cow or egg sources. Synthetic lipids don't exhibit batch-to-batch variability or the possibility of virus or protein contamination like tissue-derived lipids do as a result are a major driving factor for the market growth.

The quality and properties of synthetic lipids can be altered.

By using high-quality starting materials, enhancing the production methods, and improving the purification procedures, the purity and properties of synthetic lipids may be improved or altered and are, therefore, a major factor which is propelling the growth of the market.

Growing awareness about the superior functional properties associated with synthetic lipids is likely to fuel the market expansion

Rapid urbanisation, sedentary lifestyles, and rising fast-food consumption are all contributing factors to the growth in obesity and other health-related problems. As a result, people are becoming more health concerned, and there is a growing demand for dietary lipids worldwide. Additionally, to preserve the flavour and aroma of their goods, several food manufacturing businesses are substituting lipids for synthetic flavouring carriers. This is because of their better functional qualities, which include density, hydrogenation, and emulsification which are fueling market development.

MARKET RESTRAINTS:

The sophisticated raw material required for the manufacturing of synthetic lipids is likely to hamper the market growth

Superior and reliable raw material quality is necessary for the GMP production of synthetic liposome-based medicinal products, and properties including solubility, crystallinity, stability and flowability play crucial roles in the manufacturing process. Because they are waxy by nature, lipids, the main raw materials used to make liposomes, can dissolve slowly and present difficulties when handled in big amounts.

Lack of awareness among people about the benefits of lipids is likely to inhibit the market growth

The development of this industry is being constrained by consumers in developing nations who are not aware of the health advantages of lipids. This is due to the market for lipid nutrition experiencing restrictions due to the availability of substitute products and reduced penetration throughout the forecast period.

SYNTHETIC LIPID MARKET REPORT COVERAGE:

This research report on the Synthetic Lipid Market has been segmented and sub-segmented based on By Route of Administration, Application and By Region.

SYNTHETIC LIPID MARKET – BY ROUTE OF ADMINISTRATION

• Oral
• Parenteral
• Topical
• Others

Based on applications the, synthetic Lipids market is segmented into Oral, Parenteral, Topical and Others. The oral lipids market category had more than 40.8 per cent of the market share in 2021 when looking at the method of administration. Due to their ability to improve the solubility of poorly water-soluble, lipophilic medications as well as promote gastrointestinal absorption, oral lipid-based formulations are becoming more popular.

SYNTHETIC LIPID MARKET - BY APPLICATION

• Pharmaceuticals
• Personal Care & Cosmetics
• Food
• Others

Based on applications the, synthetic Lipids market is segmented into Pharmaceuticals, Personal Care & Cosmetics, Food and Others. Among these, the personal care and cosmetics segment was the major contributor to the market growth. Major lifestyle changes have been brought about by increased urbanisation in many locations. The personal care and cosmetics business has benefited as a result. Social media and digitization have been extremely important for cosmetics sales. In 2021, the personal care & cosmetics category accounted for a significant portion of the global lipids market—more than 46%. Due to their ability to emulsify, lipids and emulsifiers made from lipids are the main ingredients utilised in the manufacture of cosmetics. Due to the incorporation of herbal ingredients in green cosmetics and the related health advantages, there has been an increase in demand for nutritional lipids generated from plants and other biotechnological sources. Additionally, it is projected that cooperative efforts to acquire lipids, particularly for use in cosmetics, will fuel the synthetic lipids market.

SYNTHETIC LIPID MARKET - BY REGION

• North America
• Europe
• The Asia Pacific
• Latin America
• The Middle East
• Africa

By region, the Synthetic Lipid Market is grouped into North America, Europe, Asia Pacific, Latin America, The Middle East and Africa. In 2021, Asia Pacific held the highest volume share (43.7%) of the global lipids market. Due to the rise in demand for nutraceutical goods and the expansion of the pharmaceutical sector, the market in the area is anticipated to develop quickly over the projected period. Due to the rising need for lipids in the country's nutraceutical industry, India is anticipated to soon occupy the lion's share of the synthetic lipids market in the Asia Pacific. Due to the country's rising health-related worries and illnesses, India is anticipated to be a high-potential market for the nutraceutical business. From a regional or national perspective, China dominates the synthetic lipids market because of the substantial demand for lipids in the country's food and beverage and personal care & cosmetics industries. Due to the growth in per capita disposable income in the nation, the Chinese market is anticipated to grow considerably throughout the projected period.

The demand for synthetic lipids in North America and Europe has been positively affected by rising knowledge of good personal hygiene and a healthy lifestyle. In 2021, North America accounted for 19.8% of the global lipids market. Throughout the predicted period, it is anticipated that the region's share would rise even higher. In the global lipids market, Europe is also a significant region. In 2021, the European lipids market was headed by Germany. The synthetic lipids market in the area is being driven by the expansion of the pharmaceutical sector as well as a preference for a healthy lifestyle in Europe.

SYNTHETIC LIPID MARKET - BY COMPANIES

Some of the major players operating in the Synthetic Lipid Market include:

1. Archer Daniels Midland Company
2. Merck Millipore Limited
3. Stepan Company
4. NOF Corporation
5. Abitec Corporation
6. Avanti Polar Lipids Inc.
7. Cayman Chemical Company
8. Cordenpharma International
9. Chemi S.P.A.
10. Matreya Llc
11. Tokyo Chemical Industry Co., Ltd.

NOTABLE HAPPENING IN THE SYNTHETIC LIPID MARKET

• PRODUCT LAUNCH- Merck increased lipid manufacturing in May 2021 to satisfy patient demand during COVID-19. A brand-new, highly pure synthetic cholesterol product was introduced by the corporation.
• COLLABORATION- ABITEC Corporation and DKSH announce the extension of their lipid distribution agreement in September 2021.
• ACQUISITION- To expand its offering of F&F components, BASF bought Aroma Biotech in September 2019, a pioneer in isobionics innovation.